Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes

Eur J Immunol. 2014 Oct;44(10):2938-48. doi: 10.1002/eji.201444751. Epub 2014 Aug 12.

Abstract

The acquisition and maintenance of NK-cell function is mediated by inhibitory killer-cell immunoglobulin-like receptors (KIRs) through their interaction with HLA class I molecules. Recently, HLA-C expression levels were shown to be correlated with protection against multiple outcomes of HIV-1 infection; however, the underlying mechanisms are poorly understood. As HLA-C is the natural ligand for the inhibitory receptors KIR2DL1 and KIR2DL2/3, we sought to determine whether HLA-C group haplotypes affect NK-cell responses during primary HIV-1 infection. The phenotypes and functional capacity of NK cells derived from HIV-1-positive and HIV-1-negative individuals were assessed (N = 42 and N = 40, respectively). HIV-1 infection was associated with an increased frequency of KIR2DL1-3(+) NK cells. Further analysis showed that KIR2DL1(+) NK cells were selectively increased in individuals homozygous for HLA-C2, while HLA-C1-homozygous individuals displayed increased proportions of KIR2DL2/3(+) NK cells. KIR2DL1-3(+) NK cells were furthermore more polyfunctional during primary HIV-1 infection in individuals also encoding for their cognate HLA-C group haplotypes, as measured by degranulation and IFN-γ and TNF-α production. These results identify a novel relationship between HLA-C and KIR2DL(+) NK-cell subsets and demonstrate that HLA-C-mediated licensing modulates NK-cell responses to primary HIV-1 infection.

Keywords: HIV-1; HLA-C; Inhibitory killer-cell immunoglobulin-like receptors (KIRs); Natural killer (NK) cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Flow Cytometry
  • HIV Infections / genetics*
  • HIV Infections / immunology*
  • HLA-C Antigens / genetics
  • HLA-C Antigens / immunology*
  • Haplotypes
  • Humans
  • Killer Cells, Natural / immunology*
  • Lymphocyte Subsets / immunology*
  • Male
  • Middle Aged
  • Receptors, KIR2DL1 / immunology
  • Receptors, KIR2DL2 / immunology
  • Receptors, KIR2DL3 / immunology

Substances

  • HLA-C Antigens
  • KIR2DL1 protein, human
  • KIR2DL2 protein, human
  • KIR2DL3 protein, human
  • Receptors, KIR2DL1
  • Receptors, KIR2DL2
  • Receptors, KIR2DL3